Headache
Evenamide meets primary endpoint in phase 2/3 study of patients with schizophrenia
Newron Pharmaceuticals announced positive topline results from its phase 2/3 study of evenamide for patients with chronic schizophrenia who have an inadequate response to current treatment with a second-generation antipsychotic.
Headache associated with attempted, completed suicide
DENVER — Among a large cohort of Danish citizens, headache disorders were strongly associated with attempted and completed suicide, according to a presenter at the American Academy of Neurology annual meeting.
‘Good friction:’ Experts share how artificial intelligence works in their office
DENVER — Incorporating artificial intelligence into daily practice can benefit both providers and patients, according to experts here at the American Academy of Neurology annual meeting.
Atogepant well-tolerated, linked to significant migraine reduction
Treatment with atogepant was safe, effective and well-tolerated over 12 weeks in those with episodic migraine who failed multiple conventional therapies, with significant reductions in mean monthly migraine days compared with placebo.
Sleep quality, energy, stress associated with incident headache onset
Poor sleep quality and low energy on the previous day were associated with incident morning headache, while higher than average energy levels and stress were linked to later-day headache onset, researchers reported in Neurology.
Ubrogepant efficacious, well tolerated for treating migraine in prodromal phase
Treatment with 100 mg ubrogepant was effective at curbing migraine attacks when administered during the prodromal phase compared with placebo, according to research from The Lancet.
What is hypertension?
Hypertension is also known as high blood pressure. It is defined as transitory (short-lived) or chronic elevation of the blood pressure in the arteries. This elevation may lead to cardiovascular damage. When left untreated, the damage to the circulatory system can cause heart attack, stroke, heart failure, heart disease and kidney failure.
Blood pressure-lowering meds more effective than placebo at reducing migraine frequency
A systematic literature review determined that various classes of blood pressure-lowering medication reduced frequency of migraine days per month compared with placebo, according to a study published in Cephalalgia.
IV ketamine reduced pain by 50% in pediatric patients with refractory headache
AUSTIN, Texas — Treatment with IV ketamine for pediatric refractory headache resulted in a 50% reduction in pain at discharge, with nearly two-thirds of patients not requiring rescue care within 1 month, according to a poster presentation.
Highlights from the American Headache Society Annual Meeting for PCPs
Last week, Healio provided live coverage of the American Headache Society Annual Meeting in Austin, Texas, where health care professionals gathered for the latest updates on headache disorders.